CCancer Immunology Immunotherapy8d agoReal-world outcomes of ipilimumab plus nivolumab in esophageal squamous cell carcinoma: a multi-institutional large cohort studyShuichiro Hara·Yuichiro Doki·Tomoki Makino·Shigeto Nakai·Kotaro Yamashita·Koji Tanaka·Taro Satoh·Keijiro Sugimura·Ryohei Kawabata·Atsushi Takeno·Masaaki Motoori·Makoto Yamasaki·Hiroshi Miyata·Yutaka Kimura·Kota Momose·Hidetoshi Eguchi·Takushi YasudaRead at Cancer Immunology ImmunotherapyTagsCancer Immunotherapy and BiomarkersOncology
